DNA identification Italian Researchers Developing Plasmonic Biosensor for Colorectal Cancer Testing, Monitoring Premium The group is developing an ultrasensitive nanoparticle-enhanced plasmonic biosensor to detect RAS single nucleotide variants in plasma. Nanopore Platform Developers Aim to Bring Multiplex MDx Testing to Point of Care Premium The UK developers believe that their device has the potential for multiplex testing at the point of care using solid-state nanopore sensing with DNA probes. PerkinElmer Adds DNA Quality Assessment Analyzer to Agena Nucleic Acid Detection System The companies will incorporate PerkinElmer's LabChip GX Touch nucleic acid analyzer in the upfront workflow of Agena's MassArray system. Qiagen, ICMP Develop NGS-Based Workflow for Missing Persons ID The International Commission on Missing Persons and Qiagen have launched a next-generation sequencing workflow for missing persons DNA identification. Canadian Government Contributes C$300K to Species Identification Research The country's health minister said the research could help detect plant pests and mislabeled seafood, among other benefits. Dec 5, 2014 LabCorp Acquires Bode Technology Dec 15, 2011 IntegenX Nets $40M Financing to Accelerate Commercialization of DNA ID Platform Premium Aug 4, 2011 Promega to Supply Reagents for IntegenX Human DNA ID System Premium Jun 23, 2011 IntegenX Starts Early-Access Program for DNA ID System to Prep for 2012 Launch Premium May 5, 2011 Bin Laden DNA ID Would be Fast and Easy Using 'Standard' PCR Tech, Experts Say Premium Sep 23, 2010 ZyGem, Lockheed Martin Developing DNA ID Platform Based on Infrared PCR Premium Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.